Pfizer: Arthritis, Rheumatoid trials

The registry lists 152 Arthritis, Rheumatoid studies with Pfizer as lead sponsor. 2 are open to participants now and 105 have results posted.

Phase 1 24Phase 2 29Phase 3 18Phase 4 17No phase 65(a study in two phases counts in both)

Studies

Page 1 of 2. Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• A Study to Learn About a Medicine Called PF-08154225 in Participants With Autoimmune DiseasesNot yet recruitingNCT07782450Phase 1/2
• Korean Post-marketing Surveillance for Xeljanz XRRecruitingNCT04876781
• A Study to Understand How Effective is Tofacitinib When Compared to Other Advanced Treatments in Patients With Rheumatoid ArthritisCompletedNCT06418529Results posted
• A Study to Learn About the Study Medicine Called Infliximab (Genetical Recombination)[Infliximab Biosimilar 3] in People With Rheumatoid Arthritis, Ulcerative Colitis, Crohn's Disease, or PsoriasisCompletedNCT05796245Results posted
• To Estimate the Efficacy of Treatment With TNFi as Monotherapy or Combination Therapy With MTX and Compare and Contrast Efficacy With Tofacitinib as Monotherapy and Combination Therapy in a Real World Setting.CompletedNCT05576051Results posted
• Study to Evaluate Safety and Effects of Tofacitinib and Biologic Disease Modifying Antirheumatic Drugs in People Treated for Rheumatoid ArthritisCompletedNCT05572567Results posted
• A Study To Describe The Use Of Tofacitinib After Use Of Rituximab In Patients With Rheumatoid Arthritis In A Real-World SettingCompletedNCT05487703Results posted
• This is a Retrospective Observational Study Looking at the Characteristics and Outcomes of Participants Taking Inflectra Using the CorEvitas Rheumatoid Arthritis RegistryCompletedNCT05375942Results posted
• Comparative Effectiveness Of Tumor Necrosis Factor Inhibitors And Tofacitinib Use In Earlier Lines Of Therapy And Use As Monotherapy.CompletedNCT04721821Results posted
• A Study To Investigate And Describe The Treatment Patterns And Effect Of Tofacitinib Indicators For Patients With Rheumatoid ArthritisCompletedNCT04721808Results posted
• Study To Evaluate The Response To Enbrel And The Impact Of Rheumatoid Factor(RF) And Anti-Cyclic Citrullinated Peptide(Anti-CCP) In Rheumatoid Arthritis(RA) PatientsCompletedNCT04428424Results posted
• TO ASSESS THE EFFICACY AND SAFETY OF PF-06650833, PF-06651600, AND TOFACITINIB ALONE AND IN COMBINATION IN PARTICIPANTS WITH ACTIVE RHEUMATOID ARTHRITIS WITH AN INADEQUATE RESPONSE TO METHOTREXATECompletedNCT04413617Phase 2Results posted
• This Study is to Investigate the Effect of Etanercept in Early Versus Delayed Referral for Management of Rheumatoid Arthritis Patients.CompletedNCT04267614Results posted
• A Study To Compare The Effectiveness Of Tofacitinib 11 Mg Once A Day To Tofacitinib 5 Mg Twice A DayCompletedNCT04267380Results posted
• A Comparative Study Between PF-06410293 and Humira® in Combination With Methotrexate in Participants With Active Rheumatoid ArthritisCompletedNCT04230213Phase 3Results posted
• Predictors of Response to Tofacitinib Treatment in Rheumatoid Arthritis PatientsCompletedNCT04079920Results posted
• A Study to Evaluate Patient Characteristics and Treatment Patterns Among Rheumatoid Arthritis PatientsCompletedNCT04047121Results posted
• Comparative Analysis of Adherence and Effectiveness Outcomes Between Rheumatoid Arthritis (RA) Patients Treated With Tofacitinib Modified Release (MR)CompletedNCT04018001Results posted
• Changes of Depression After First-year of Tofacitinib in RA PatientsCompletedNCT03992781Results posted
• IDentification of Factors Predictive of Tofacitinib's Survival in Patient With Rheumatoid ArthritisCompletedNCT03981900Results posted
• Comparative Analysis of Outcomes Among Patients Initiating Xeljanz in Combination With Oral MTX Who Withdraw MTX Versus Continue MTXCompletedNCT03975790Results posted
• Comparative Analysis of Outcomes Among Patients Treated With Xeljanz vs BiologicsCompletedNCT03964649Results posted
• Infliximab Biosimilar for Intravenous Drip Infusion 100 mg "Pfizer" Drug Use Investigation (Rheumatoid Arthritis)CompletedNCT03885037Results posted
• Rheumatoid Arthritis Satisfaction Outcome ResearchCompletedNCT03703817Results posted
• Observational Study to Determine How Physicians Make Treatment Decisions in Patients Treated With Tofacitinib for Moderate to Severe Active Rheumatoid ArthritisCompletedNCT03387423Results posted
• Safety and Tolerability Study Of PF-06835375 In Subjects With Seropositive Systemic Lupus Erythematosus Or Rheumatoid ArthritisCompletedNCT03334851Phase 1Results posted
• Patient-Reported Outcomes In Rheumatoid Arthritis Patients Treated With Tofacitinib Or Biological Disease-Modifying Antirheumatic Drugs (DMARDs) In Real Life ConditionsCompletedNCT03073109Results posted
• Safety and Efficacy of Pf-06650833 In Subjects With Rheumatoid Arthritis, With An Inadequate Response To MethotrexateCompletedNCT02996500Phase 2Results posted
• Korean Post-marketing Surveillance for XeljanzCompletedNCT02984020Results posted
• Study To Assess The Efficacy And Safety Of Pf-06651600 In Subjects With Rheumatoid Arthritis With An Inadequate Response To MethotrexateCompletedNCT02969044Phase 2Results posted
• National Observational Study On The Use Of Inflectra™ An Infliximab Biosimilar In Real LifeCompletedNCT02925338Results posted
• Methotrexate Withdrawal Study of Tofacitinib Modified Release Formulation in Subjects With Rheumatoid ArthritisCompletedNCT02831855Phase 4Results posted
• Post-Marketing Use Of CT-P13 (Infliximab) For Standard Of Care Treatment Of Rheumatoid Diseases Who Are Naïve To Biologics Or Switched From RemicadeCompletedNCT02605642Results posted
• A Study To Evaluate The Efficacy Of Enbrel (REGISTERED) Etanercept Over A Period Of 12 Months In The Routine Treatment Of Patients With Rheumatoid Arthritis, Axial Spondyloarthritis, Psoriatic Arthritis, Or Plaque Psoriasis.CompletedNCT02486302Results posted
• A Study Of PF-06410293 (Adalimumab-Pfizer) And Adalimumab (Humira®) In Combination With Methotrexate In Subjects With Active Rheumatoid Arthritis (REFLECTIONS B538-02).CompletedNCT02480153Phase 3Results posted
• Study to Assess the Immunogenicity, Safety, and Efficacy of High Capacity Process Etanercept in Rheumatoid Arthritis SubjectsCompletedNCT02378506Phase 3Results posted
• A Study To Evaluate The Safety And Efficacy Of Tofacitinib Modified Release Tablets Compared To Tofacitinib Immediate Release Tablets In Adult Patients With Rheumatoid ArthritisCompletedNCT02281552Phase 3Results posted
• A Study of PF-06438179 (Infliximab-Pfizer) and Infliximab in Combination With Methotrexate in Subjects With Active Rheumatoid Arthritis (REFLECTIONS B537-02).CompletedNCT02222493Phase 3Results posted
• Study With Etanercept Focusing on Remission and Predictability of Remission in Real Life Clinical PracticeCompletedNCT02202837Results posted
• A Study to Assess Immune Response Following Zoster Vaccination to Subjects With Rheumatoid Arthritis Receiving Tofacitinib or Placebo With Background MethotrexateCompletedNCT02147587Phase 2Results posted
• Safety Study Of Tofacitinib Versus Tumor Necrosis Factor (TNF) Inhibitor In Subjects With Rheumatoid ArthritisCompletedNCT02092467Phase 4Results posted
• Drug Concentration, Immunogenicity, and Efficacy Study in Patients With Rheumatoid Arthritis Currently Treated With Etanercept, Adalimumab, or InfliximabCompletedNCT01981473Results posted
• Tofacitinib (Xeljanz) Special Investigation for Rheumatoid ArthritisCompletedNCT01932372Results posted
• Study to Observe the Safety and Efficacy of Etanercept (Enbrel®) in Patients With Moderately Active Rheumatoid Arthritis in Every Day Clinical Practice in AustriaCompletedNCT01877239Results posted
• Study of Etanercept in Subjects With Rheumatoid Arthritis Who Have Had an Inadequate Response to Adalimumab or Infliximab Plus MethotrexateTerminatedNCT01783015Phase 4Results posted
• Co-Administration Of Methotrexate And CP-690,550CompletedNCT01745055Phase 1Results posted
• Formation of Antibodies and Subsequent Prediction of Clinical Response in Patients With Rheumatoid Arthritis Treated With Four TNF Blocking AgentsTerminatedNCT01691014Results posted
• Study to Assess the Safety and Efficacy of Etanercept in Patients Treated Over the Long-term in Real-world Clinical Practice, Using Data Collected by the British Society of Rheumatology Biologics RegistryCompletedNCT01646385Results posted
• Rheumatoid Arthritis Extension Trial For Subjects Who Have Participated In Other PF-05280586 Trials (REFLECTIONS B328-04)CompletedNCT01643928Not applicableResults posted
• Prospective Evaluation of the Radiographic Efficacy of EnbrelCompletedNCT01623752Results posted
• Study Conducted in Subjects With Rheumatoid Arthritis Who Have Moderate to Severe Disease Activity Despite Methotrexate Therapy With or Without Other Non Biologic Disease Modifying Antirheumatic Drugs (DMARDs)for at Least 12 Weeks Prior to ScreeningCompletedNCT01578850Phase 4Results posted
• Good EULAR Response In Patients With Early Rheumatoid ArthritisCompletedNCT01558089Results posted
• Characterize Patients With Moderately Active Rheumatoid Arthritis (RA)CompletedNCT01557322Results posted
• A Pharmacokinetic/Pharmacodynamic Study Comparing PF-05280586 To Rituximab In Subjects With Active Rheumatoid Arthritis With An Inadequate Response To TNF Inhibitors (REFLECTIONS B328-01)CompletedNCT01526057Phase 2Results posted
• Study Looking at Longitudinal Changes in Fatigue and Health Status in Rheumatoid Arthritis (RA) Patients Treated With Subcutaneous Anti-TNF-α TherapyCompletedNCT01521884Results posted
• A Study To Evaluate The Effect Of CP-690,550 On Measures Of Kidney Function In Patients With Active Rheumatoid ArthritisCompletedNCT01484561Phase 1Results posted
• Correlation Between Beliefs About Medicine and Objective Measures of Efficacy and Safety in Rheumatoid Arthritis (RA)CompletedNCT01432366Results posted
• A Study of Rheumatoid Arthritis Treatment With Enbrel in Adult Patient in Outpatient DepartmentTerminatedNCT01411215Results posted
• Study Comparing Doses Of An Experimental Glucocorticoid Compound To Prednisone And Placebo In Rheumatoid ArthritisCompletedNCT01393639Phase 2Results posted
• A Study To Assess the Immune Response Following Administration Of Influenza and Pneumococcal Vaccines To Subjects With Rheumatoid Arthritis Receiving CP-690,550 Or PlaceboCompletedNCT01359150Phase 2Results posted
• Effects Of CP-690,550 (Tasocitinib) On Cholesterol Metabolism In Patients With Active Rheumatoid ArthritisCompletedNCT01262118Phase 1Results posted
• Effects of Tofacitinib (CP-690,550) on Magnetic Resonance Imaging (MRI)- Assessed Joint Structure In Early Rheumatoid Arthritis (RA)CompletedNCT01164579Phase 2Results posted
• Study Of The Effects Of Atorvastatin On Cholesterol Levels In Rheumatoid Arthritis Patients Taking CP-690,550CompletedNCT01059864Phase 2Results posted
• Comparing The Effectiveness And Safety Of 2 Doses Of An Experimental Drug, CP-690,550, To Methotrexate (MTX) In Patients With Rheumatoid Arthritis Who Have Not Previously Received MTXCompletedNCT01039688Phase 3Results posted
• A Study To Evaluate The Mechanism Of Action Of CP-690,550 In Patients With Rheumatoid ArthritisCompletedNCT00976599Phase 2Results posted
• Study of CP-690,550 Versus Placebo In Rheumatoid Arthritis Patients On Background Methotrexate With Inadequate Response To Tumor Necrosis Factor (TNF) InhibitorsCompletedNCT00960440Phase 3Results posted
• A Study Of PF-04171327 In The Treatment Of The Signs And Symptoms Of Rheumatoid ArthritisCompletedNCT00938587Phase 2Results posted
• Retrospective Evaluation of the Radiographic Efficacy of Conventional and Biologic TreatmentCompletedNCT00929357Results posted
• Study Evaluating Etanercept Plus Methotrexate in Early Rheumatoid ArthritisCompletedNCT00913458Phase 4Results posted
• Study To Evaluate The Safety And Efficacy Of ILV-094 In Subjects With Rheumatoid ArthritisCompletedNCT00883896Phase 2Results posted
• Study Comparing The Effect On Disease Activity When Reducing Or Discontinuing Etanercept In Subjects With RACompletedNCT00858780Phase 4Results posted
• A Study Comparing 2 Doses Of CP-690,550 Vs. Placebo For The Treatment Of Rheumatoid Arthritis In Patients On Other Background Arthritis MedicationsCompletedNCT00856544Phase 3Results posted
• A Phase 3 Study Comparing 2 Doses Of CP-690,550 And The Active Comparator, Humira (Adalimumab) Vs. Placebo For Treatment Of Rheumatoid ArthritisCompletedNCT00853385Phase 3Results posted
• Open-Label Study Comparing Etanercept to Conventional Disease Modifying Antirheumatic Drug (DMARD) TherapyCompletedNCT00848354Phase 4Results posted
• A 2-Year Phase 3 Study Of CP-690,550 In Patients With Active Rheumatoid Arthritis On Background MethotrexateCompletedNCT00847613Phase 3Results posted
• Phase I Study Of The Safety, Tolerability, Pharmacokinetics And Pharmacodynamics Of Multiple Intravenously Administered Doses Of PF-04236921 In Patients With Rheumatoid ArthritisCompletedNCT00838565Phase 1Results posted
• A Phase 3 Study Comparing 2 Doses of CP-690,550 vs. Placebo for Treatment of Rheumatoid ArthritisCompletedNCT00814307Phase 3Results posted
• Drug Outcome Survey for Biological Treatments in Rheumatoid Arthritis: an Observational Study (Dose)CompletedNCT00794118Results posted
• Current Adoption of Composite Indices in Evaluating Rheumatoid Arthritis Patients: An Observational StudyCompletedNCT00793403Results posted
• Evaluation of EULAR-RAID Score in Rheumatoid Arthritis PatientsCompletedNCT00768053Phase 4Results posted
• Study Evaluating Efficacy / Safety of Etanercept + Methotrexate Compared to Usual Treatment in Moderate RA SubjectsTerminatedNCT00706797Phase 4Results posted
• Comparison Of 5 CP-690,550 Doses Vs. Placebo, For The Treatment Of Rheumatoid Arthritis In JapanCompletedNCT00687193Phase 2Results posted
• Long-Term, Open-Label Study Of CP-690,550 For Treatment Of Rheumatoid Arthritis In JapanCompletedNCT00661661Phase 3Results posted
• A Study of ARRY-438162 in Patients With Rheumatoid ArthritisCompletedNCT00650767Phase 2Results posted
• Study Evaluating 2 Dosing Regimens Of TRU-015 In Rheumatoid ArthritisTerminatedNCT00634933Phase 2Results posted
• Study of CE-224,535 A Twice Daily Pill To Control Rheumatoid Arthritis In Patients Who Have Not Totally Improved With MethotrexateCompletedNCT00628095Phase 2Results posted
• Comparison Of 4 CP-690,550 Doses Vs. Placebo, Each Combined With Methotrexate, For The Treatment Of Rheumatoid Arthritis in JapanCompletedNCT00603512Phase 2Results posted
• Study Comparing Etanercept in Combination With Methotrexate in Subjects With Rheumatoid ArthritisCompletedNCT00565409Phase 4Results posted
• A Phase 2 Study For Patients With A Physician's Diagnosis Of Rheumatoid ArthritisCompletedNCT00550446Phase 2Results posted
• Study Evaluating the Safety and Efficacy of Enbrel (Etanercept) in JapanCompletedNCT00503139Results posted
• Observational Trial With EnbrelCompletedNCT00488475Results posted
• Study Comparing Perceptions and Satisfaction for Two Different Delivery Mechanisms for EtanerceptCompletedNCT00459706Phase 3Results posted
• Study Evaluating the Efficacy and Safety of Etanercept and Methotrexate in Japanese Subjects With Rheumatoid ArthritisCompletedNCT00445770Phase 3Results posted
• Maraviroc in Rheumatoid ArthritisTerminatedNCT00427934Phase 2Results posted
• A Study Of CP-195543 And Celecoxib Dual Therapy In Subjects With Rheumatoid ArthritisTerminatedNCT00424294Phase 2Results posted
• Study Comparing Etanercept With Usual DMARD Therapy in Subjects With Rheumatoid Arthritis in the Asia Pacific RegionCompletedNCT00422227Phase 4Results posted
• Open Label, Dose-Regimen Study Evaluating Etanercept 50 mg Once-Weekly In Japanese Subjects With RACompletedNCT00418717Phase 3Results posted
• Long-Term Safety Follow-Up Of Subjects Previously Enrolled In Rheumatoid Arthritis Studies Of CP-690,550CompletedNCT00414661Results posted
• Long-Term Effectiveness And Safety Of CP-690,550 For The Treatment Of Rheumatoid ArthritisCompletedNCT00413699Phase 3Results posted
• Comparison Of 6 CP-690,550 Doses Vs.Placebo, Each Combined With Methotrexate, For The Treatment Of Rheumatoid ArthritisCompletedNCT00413660Phase 2Results posted